LA JOLLA, Calif., July 25, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that C.J. Barnum, Director of Neuroscience and R.J. Tesi, M.D., the company?s co-founder, and CEO, will present at the
News
INmune Bio, Inc. Prices Public Offering of Common Stock
LA JOLLA, Calif, July 16, 2020 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, toda… […]
News
INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute?s 7th Annual Immuno-Oncology Summit
LA JOLLA, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that RJ Tesi, M.D., co-found… […]
News
INmune Bio, Inc. Schedules Conference Call to Report 2020 Second Quarter Financial Results
LA JOLLA, Calif, July 31, 2020 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today… […]
